Edition:
United States

Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

142.70SEK
18 Aug 2017
Change (% chg)

-1.90kr (-1.31%)
Prev Close
144.60kr
Open
143.80kr
Day's High
144.10kr
Day's Low
141.30kr
Volume
1,036,369
Avg. Vol
1,217,358
52-wk High
184.70kr
52-wk Low
136.90kr

Latest Key Developments (Source: Significant Developments)

Getinge resolves on fully guaranteed 4 bln SEK rights issue
Friday, 18 Aug 2017 05:30am EDT 

Aug 18 (Reuters) - Getinge Ab :says today, the Board of Directors of Getinge AB, with authorization from the Extraordinary General Meeting on August 15, 2017, has resolved on a rights issue of MSEK 4,324 with the purpose to strengthen the group’s balance sheet by reducing leverage and thereby providing improved operational flexibility.says subscription price in rights issue is sek 127 per share.says main shareholder, carl bennet ab has undertaken to subscribe for its portion of rights issue and committed to subscribe for shares that are not subscribed for in rights issue.says fourth swedish national pension fund has expressed its intention to subscribe for its portion of rights issue.says rights issue will, if fully subscribed, increase getinge's share capital by sek 17,023,098, from current sek 119,161,688.50.Getinge announced plans for the rights issue on June 14 nL8N1JB2HV.  Full Article

Getinge to cooperate with Brazilian authorities on cartel probe
Thursday, 3 Aug 2017 10:00am EDT 

Aug 3 (Reuters) - Getinge AB :Getinge says to cooperate with Brazilian authorities on local ongoing investigations.Says it is currently presumed that outcome of ongoing investigations will not have a material financial impact on group.Says that at this early stage of the process impact cannot be excluded.Getinge says investigation is part of ongoing public investigations on cartel activities related to sales of medical equipment and is being carried out by Brazilian authorities.  Full Article

BRIEF-Getinge Q2 core profit lags forecast, makes new provision over Hechingen
Monday, 17 Jul 2017 02:20am EDT 

Repeats to additional alerts:Q2 EBITA before acquisition, restructuring and integration costs increased 9.6% to SEK 864 m (788)..Q2 Order intake increased by 1.1% to SEK 7,539 M (7,460). The order intake declined organically by 3.8%. .Reuters Poll: Getinge Q2 order intake was seen at 7.8 bln SEK, Adj. EBITA at 909 mln.Says restructuring and integration costs amounted to SEK 524 M (133), of which SEK 488 M comprised a provision for improvements in Hechingen in accordance with the Consent Decree with the FDA. .A replanning of the ongoing remediation program has been conducted in Hechingen, Germany, and the Group has decided to make an additional provision of SEK 488 M to make the necessary changes..Net sales rose by 4.5% to SEK 7,241 M (6,927). Net sales decreased organically by 0.5%. .Getinge says organic sales growth is is deemed to be slightly positive in 2017. .Says Lars Sandström has been appointed Chief Financial Officer (CFO) and member of Getinge Executive Team..  Full Article

Getinge makes provision of additional SEK 488 mln over Hechingen
Monday, 17 Jul 2017 02:00am EDT 

July 17 (Reuters) - Getinge :Getinge has replanned the remediation in Hechingen (DE) related to the consent decree with FDA and makes a provision of additional SEK 488 mln.Says costs are primarily attributable to increased staffing and process validation.Says after decided provision group has a total remaining provision of SEK 710 mln.  Full Article

Getinge Q2 core profit lags forecast, makes new provision over Hechingen
Monday, 17 Jul 2017 02:00am EDT 

July 17 (Reuters) - Getinge :Q2 EBITA before acquisition, restructuring and integration costs increased 9.6% to SEK 864 m (788)..Q2 Order intake increased by 1.1% to SEK 7,539 M (7,460). The order intake declined organically by 3.8%. .Reuters Poll: Getinge Q2 order intake was seen at 7.8 bln SEK, Adj. EBITA at 909 mln.Says restructuring and integration costs amounted to SEK 524 M (133), of which SEK 488 M comprised a provision for improvements in Hechingen in accordance with the Consent Decree with the FDA. .A replanning of the ongoing remediation program has been conducted in Hechingen, Germany, and the Group has decided to make an additional provision of SEK 488 M to make the necessary changes..Net sales rose by 4.5% to SEK 7,241 M (6,927). Net sales decreased organically by 0.5%. .Getinge says organic sales growth is is deemed to be slightly positive in 2017. .Says Lars Sandström has been appointed Chief Financial Officer (CFO) and member of Getinge Executive Team..  Full Article

Hanza signs agreement with Getinge
Thursday, 6 Jul 2017 06:40am EDT 

July 6 (Reuters) - HANZA AB :HANZA SIGNS AGREEMENT WITH GETINGE.  Full Article

Getinge says two of its entities investigated by Brazilian authorities
Monday, 26 Jun 2017 01:54am EDT 

STOCKHOLM, June 26 (Reuters) - Getinge :* Says investigation by the Brazilian Administrative Council for Economic Defense comprises two Getinge entities.* Two of Getinge’s entities in Brazil, Maquet Cardiopulmonary do Brasil Indústria e Comércio Ltda and Maquet do Brasil Equipamentos Médicos Ltda, and employees within these companies are being investigated .* Says investigation is part of ongoing public investigations on cartel activities related to the sales of medical equipment and is being carried out by the Brazilian authorities.* Says potential consequences for Getinge are not yet known and too early to comment upon.  Full Article

Getinge says plans guaranteed rights issue of approximately SEK 4 bln
Wednesday, 14 Jun 2017 06:15am EDT 

June 14 (Reuters) - Getinge :Says plans guaranteed rights issue of approximately SEK 4 billion.Says is planning a new share issue of approximately SEK 4 billion to strengthen group's balance sheet by reducing debt and thereby creating greater scope for action.Says work on planned spin-off is proceeding according to previously announced plan.Says principal owner, Carl Bennet AB, representing 18.1 pct of share capital and 48.9 pct of number of votes in Getinge, has undertaken to vote in favor of and subscribe for its portion of new share issue.Furthermore, in an agreement with Getinge, Carl Bennet AB has undertaken to subscribe for the shares that potentially are not subscribed and paid for by the remaining shareholders.The Fourth Swedish National Pension Fund has expressed support for the right issue and has the intention to subscribe for its portion.  Full Article

Getinge: can't rule out more costs related to FDA quality control probe
Thursday, 26 Jan 2017 10:07am EST 

Getinge Ab CEO told analysts and media in a conference call: cannot rule out additional requirements from fda, costs related to fda quality controls probe . complementary acquisitions is as always on agenda Further company coverage: [GETIb.ST] (Reporting By Anna Ringstrom) ((Anna.Ringstrom@thomsonreuters.com;)).  Full Article

Getinge Q4 core profit below expectations
Thursday, 26 Jan 2017 07:00am EST 

Getinge : Q4 net sales increased by 1.1% to sek 9,523 m (9,417). . Getinge q4 order intake increased by 3.1% to sek 8,582 m (8,326). Order intake declined organically by 1.1%. . Says outlook for 2017: slightly positive organic sales growth for full-year. . Getinge q4 ebita. improved by 2.6% to sek 1,970 m (1,920) . Says a dividend per share of sek 2.00 (2.80) is proposed, corresponding to sek 477 m (667). . Says continued remediation activities related to consent decree with fda . Says currency transaction effects are expected to have a positive impact of approximately sek 200 m on the group’s 2017 earnings . Fin consequences of the consent decree with the fda., ex reconstruction costs, are related to loss of revenue and are expected to have a negative impact of abt sek 50 m on 2017 operating profit . Is still awaiting the fda’s decision on the action plan related to the production unit in hechingen .Reuters poll: getinge q4 order intake was seen at 8,561 million sek, adjusted. Ebita at 2,156 million.  Full Article

BRIEF-Getinge resolves on fully guaranteed 4 bln SEK rights issue

* says today, the Board of Directors of Getinge AB, with authorization from the Extraordinary General Meeting on August 15, 2017, has resolved on a rights issue of MSEK 4,324 with the purpose to strengthen the group’s balance sheet by reducing leverage and thereby providing improved operational flexibility